生活方式干预疗法在多囊卵巢综合征治疗中的作用

摘要/Abstract

摘要：

多囊卵巢综合征（PCOS）是一种多起因、异质性的女性内分泌系统疾病,影响患者生殖及代谢，并发心血管病及精神心理问题风险增高。生活方式干预疗法能够减轻月经紊乱、多毛痤疮等症状并有利于治疗不孕，延缓远期代谢综合征的发生，改善生活质量。因而成为PCOS患者尤其合并肥胖者重要的一线治疗方案。

关键词: 多囊卵巢综合征, 生活方式干预疗法, 肥胖, 不孕, 代谢综合征

Abstract:

Abstract:Polycystic ovary syndrome is a multi-factor and heterogeneous disorder in female reproductive endocrine system. Women with PCOS are thought to be affected by infertility and metabolic disorders, in addition with increased risks of cardiovascular diseases and psychological disorders. In PCOS patients especially with obesity or overweight, lifestyle modification has been adopted as the initial treatment strategy, from the reproductive perspective as improving symptoms such as menses irregularities, hirsutism, acnes and the infertility, as well as the metabolic and life-quality perspectives in preventing long-term metabolic complications and adjusting to a healthy psycho-physical-social status.

Key words: polycystic ovary syndrome, lifestyle modification therapy, obesity, infertility, metabolic syndrome

中图分类号:

R711.75

杨爽1,金丽娜2,郁琦2. 生活方式干预疗法在多囊卵巢综合征治疗中的作用[J]. 中国实用妇科与产科杂志.

参考文献



[1］ Ghina G, William HK, Michael BA, et al. Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women polycystic ovary syndrome［J］. Fertil Steril,2003,79(3):562-566.

[2］ Legro RS. Polycystic ovary syndrome. Phenotype to genotype［J］. Endocrinol Metab Clin North Am,1999,28,379-396.

[3］ Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women's health aspects of polycystic ovary syndrome(PCOS): the Amesterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group ［J］. Fertil Steril,2012,97(1)：28-38.

[4］ Legro RS, Castraeane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls［J］．Obstet Gynecol Surv, 2004, 28：882-892.

[5］ Balen AH, Conway GS, Homburg R, et a1. Polycystic ovary syndrome：A guide to clinical management［M］. London: Taylor and Francis, 2005：178-181.

[6］ Katz VL, Lentz G, Lobo RA, et al. Comprehensive Gynecology［M］. 5th ed. Philadelphia, PA: Mosby-Elasevier, 2007:987.

[7］ Legro RS, Kunselman AR, Dodson WC, et al.Prevalence and predictors of risk for type 1 diabetes and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women［J］. J Clin Endocrinol Metab,1999,84:165-169.

[8］ Carmina E. Metabolic syndrome in polycystic ovary syndrome［J］. Minerva Ginocol, 2011,58:109-114.

[9］陶瞍，刘伟，赵爱民, 等. 不同表型多囊卵巢综合征患者代谢综合征患病特点及风险研究［J］. 中华内分泌代谢杂志, 2013, 29:200-205.

[10］ Lisa J, Pasquali R, Helena J, et al.Treatment of obesity in polycycstic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society［J］. Fertil Steril,2009,92(6),1966-1982.

[11］ Lord J, Thomas R, Fox B,et al. The central issue? Visceral fat mass is a good marker of insulin resistantce and metabolic disturbance in women with polycystic ovary syndrome［J］. BJOG,2006,113:1203-1209. 

[12］ Hollmann M,Runnebaum B,Gerhard I. Effects of weight loss on the hormonal profile in obese,infertile women［J］. Hum Repord, 1996,11:1884-1891.

[13］ Apridonidze T, Essah PA, Iuomo MJ, et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome［J］. J Clin Endocrinol Metab,2005,90(4):1929-1935. 

[14］ Guzick DS, Wing R, Smith D, et al. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women［J］. Fertil Steril, 1994,61:598-604.

[15］ Moaran LJ, Hutchlson SK, Norman RJ, et al. Lifestyle changes in women with polycystic ovary syndrome［J］. Cochrane Database Syst Rev,2011,(2):CD007506. 

[16］ Teede HJ, Misso ML, Deeks AA,et al. Guideline Development Groups.Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline［J］. Med J Aust,2011,195(6):S65-112.

[17］陈子江.多囊卵巢综合征--基础与临床［M］.北京:人民卫生出版社,2009:123.

[18］ Anderson JW, Konz EC ,Frederich RC,et al. Long-term weight-loss maintenance: a meta-analysis of UW studies［J］. Am J Clin Nutr,2001,74:579-584.

[19］ Dilorenzo TM, Bargman EP, Stycky-Ropp R, et al. Long-term effects of aerobic exercese on psychological outcomes［J］. Prev Med,1999,28:75-85.

[20］ Schmitz KH, Hannan PJ, Stovitz SD,et al. Strength training and adiposity in premenopausal women: strong, healthy , and empowered study［J］. Am J Clin Nutr, 2007,86:566-572.

[21］ Stiegler P, Cunliffe A. The role of diet and exercise for the maintenance of fat-free mass and resting metabolic rate during weight loss［J］. Sports Med,2006,36:239-262.

[22］ Thomson RL, Buckley JD, Brinkworth GD. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature［J］. Obesity Reviews, 2011,12:e202-210.

[23］ Vigorito C, Giallauria F, Palomba S,et al. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome［J］. J Clin Endocrinol Metab,2007,92:1379-1384.

[24］ Palomba S, Giallauria F, Falbo A, et al. Structured exercise training programme versus hypocaloric hyperprotein diet in obese polycystic ovary syndrome patients with anovulatory infertility : a 24-week pilot study［J］. Hum Reprod,2008:23:624-650.

[25］ Thomson RL, Buckley JD, Lim SS,et al. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome［J］. Fertil Steril, 2010,94(5):1812-1816.

[26］ Shi X，Zhang L，Fu S，et a1．Co-involvement of psychological and neurological abnormalities in infertility with polycystic ovarian syndrome［J］. Arch Gynecol Obstet,2011,284:773-778.

[27］ Li Y, Li Y, Yu Ng EH．Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis［J］. Fertil Steril,2011,96:452-458．

[28］ Downey J, Yingling S, McKinney M, et al. Mood disorders,psychiatric symptoms,and distress in women presenting for infertility evaluation［J］. Fertil Steril, 1989,52:425-432.

[29］ Pasquall R, Gambineri A, Blscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome［J］. J Clin Endocrinol Metab, 2000,85:2767-2774.

[30］ Palomba S, Falbo A, Glallauria F, et al.Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial［J］. Hum Reprod,2010,25:2783-2791.

[31］ Moran LJ, Brinkworth G, Noakes M, et al. Effects of lifestyle modification in polycystic ovarian syndrome［J］. Reprod Biomed Online,2006,12(5):569-578.

[1]	邓姗, 田秦杰. 子宫内膜息肉与生育[J]. 中国实用妇科与产科杂志, 2022, 38(3): 273-276.
[2]	郁琦. 生殖健康与补充多种微量营养素的中国专家共识[J]. 中国实用妇科与产科杂志, 2021, 37(4): 453-456.
[3]	冷金花，李晓燕. 子宫内膜异位症诊治中有争议的几个问题[J]. 中国实用妇科与产科杂志, 2021, 37(3): 273-276.
[4]	刘芬婷, 李蓉. 女性生殖道感染对辅助生殖技术妊娠结局的影响#br#[J]. 中国实用妇科与产科杂志, 2021, 37(10): 1007-1012.
[5]	孙莹璞，卜志勤. 重视不孕症的子宫因素及其处理[J]. 中国实用妇科与产科杂志, 2020, 36(6): 481-482.
[6]	熊玉晶，徐艳文. 不孕症合并慢性子宫内膜炎的诊治[J]. 中国实用妇科与产科杂志, 2020, 36(6): 488-491.
[7]	古芳. 不孕症合并子宫内膜息肉的临床处理及预后[J]. 中国实用妇科与产科杂志, 2020, 36(6): 491-495.
[8]	宋天然，孙海翔. 子宫内膜损伤致不孕症的临床处理[J]. 中国实用妇科与产科杂志, 2020, 36(6): 500-504.
[9]	石一复，李娟清. 不孕症合并子宫肌瘤的处理原则[J]. 中国实用妇科与产科杂志, 2020, 36(6): 512-516.
[10]	冷金花，史精华. 子宫腺肌病合并不孕治疗策略[J]. 中国实用妇科与产科杂志, 2020, 36(6): 516-519.
[11]	邓姗，田秦杰. 子宫发育异常合并不孕症的诊治策略[J]. 中国实用妇科与产科杂志, 2020, 36(6): 519-523.
[12]	郎景和. 对子宫内膜异位症认识的历史、现状与发展[J]. 中国实用妇科与产科杂志, 2020, 36(3): 193-196.
[13]	乔杰，齐新宇，徐雅兰，庞艳莉. 关注影响女性健康的重要生殖内分泌疾病多囊卵巢综合征[J]. 中国实用妇科与产科杂志, 2020, 36(1): 1-9.
[14]	张丹丹，卢美松. 子宫肌瘤与生育及妊娠安全的相关问题[J]. 中国实用妇科与产科杂志, 2019, 35(8): 864-868.
[15]	刘冬，黄薇. 子宫腺肌病的助孕策略[J]. 中国实用妇科与产科杂志, 2019, 35(5): 519-521.